All charts and data below are with dividends reinvested. (Inflation adjustment is OFF !)
IHE total return snapshot: IHE returned +38.73% over the past year and +4.73% YTD, with dividends reinvested. Since May 5, 2006, IHE is up +610.30% in nominal total return, or +10.28%/yr, and is currently ā3.27% below its total-return high on Feb. 27, 2026.
| Fri 2006-05-05? to Tue 2026-05-19 |
YTD
Return |
1 Year
Return |
||||
|---|---|---|---|---|---|---|
| IHE × |
+4.73%
2026-05-19 |
+38.73%
2026-05-19 |
||||
| iShares U.S. Pharmaceuticals ETF Exchange-Traded Fund | ||||||
| Fri 2006-05-05? to Tue 2026-05-19 |
Overall
Return |
Exponential
Trendline |
||||
|---|---|---|---|---|---|---|
| IHE × |
+610.30%
+10.28%/yr |
+10.50%/yr
(R2=0.904) |
||||
| iShares U.S. Pharmaceuticals ETF Exchange-Traded Fund | ||||||
| Fri 2006-05-05? to Tue 2026-05-19 |
Start
Value |
End
Value |
||||
|---|---|---|---|---|---|---|
| IHE × |
$10,000.00
2006-05-05 |
$71,030.36
2026-05-19 |
||||
| iShares U.S. Pharmaceuticals ETF Exchange-Traded Fund | ||||||
| Year | IHE |
|---|---|
| 2026 (YTD) | +4.73% |
| 2025 | +31.69% |
| 2024 | +8.13% |
| 2023 | +1.06% |
| 2022 | ā4.87% |
| 2021 | +13.07% |
| 2020 | +13.66% |
| 2019 | +15.47% |
| 2018 | ā7.76% |
| 2017 | +10.64% |
| 2016 | ā11.75% |
| 2015 | +8.81% |
| 2014 | +29.90% |
| 2013 | +40.59% |
| 2012 | +13.38% |
| 2011 | +20.94% |
| 2010 | +12.71% |
| 2009 | +30.11% |
| 2008 | ā14.92% |
| 2007 | +2.37% |
| 2006 | +6.50% |
| Fri 2006-05-05? to Tue 2026-05-19 |
Current
Drawdown |
Worst
Drawdown |
||||
|---|---|---|---|---|---|---|
| IHE × |
ā3.27%
from 2026-02-27 peak |
ā38.20%
2009-03-05 from 2007-05-22 peak |
||||
| iShares U.S. Pharmaceuticals ETF Exchange-Traded Fund | ||||||
| Period ending Tue 2026-05-19 |
1
Year |
2
Years |
3
Years |
5
Years |
10
Years |
|
|---|---|---|---|---|---|---|
| IHE × | +38.73% |
+38.92% +17.82%/yr |
+58.03% +16.47%/yr |
+57.63% +9.53%/yr |
+122.45% +8.32%/yr |
|
| iShares U.S. Pharmaceuticals ETF Exchange-Traded Fund | ||||||